Search Results for: FORMULATION DEVELOPMENT TECHNOLOGY A Novel
Articles
Patheon Selected by Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology April 25, 2016
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement with...Patheon Selected By Grünenthal to Develop Drugs Using INTAC(R) Abuse-Deterrent Formulations Technology April 19, 2016
Patheon, the leading global provider of pharmaceutical development and manufacturing services today announced it has signed a strategic agreement...Capsugel & Pulmatrix Enter Collaboration to Develop & Manufacture Novel Inhaled Therapeutics February 16, 2016
Capsugel and Pulmatrix, Inc. have recently formed a collaboration to develop novel inhaled therapeutics to treat serious pulmonary diseases. The...NANOSCALE COMPLEXES - A Novel Nanotechnology-Based Platform to Optimize Combination Cancer Therapies: Rational Development & Improved Delivery Using CombiPlex® January 7, 2016
Barry D. Liboiron, PhD; Arthur C. Louie, MD; et al describe how CombiPlex addresses the challenges facing the traditional development path of many contemporary drug combinations and provide clinical proof-of-principle evidence that this approach can yield marked improvements in efficacy and patient outcomes.
Ashland Aids Pharmaceutical Manufacturers With Formulation Services December 8, 2015
Pharmaceutical scientists at Ashland understand how polymers interact with complex drug molecules. These experts presented at CPhI India to explain...ADVANCED DELIVERY DEVICES - Implantable Drug-Eluting Devices: A Novel Approach to Patient Care October 6, 2015
Samuel D. Trohman, MBA, Joey L. Glassco, Elena Draganoiu, PhD, and Carey Boyum present developmental and commercial examples of non-biodegradable drug-eluting devices, along with the versatile properties of thermoplastic polyurethanes for the development of effective drug delivery systems.
Glenmark Pharmaceuticals' Novel Monoclonal Antibody to Enter Phase II September 8, 2015
Glenmark Pharmaceuticals S.A. recently announced that GBR 830, a novel monoclonal antibody has completed clinical Phase I dosing. GBR 830...HOT MELT EXTRUSION - OptiMelt™ Hot Melt Extrusion Technology to Improve Bioavailability of Poorly Soluble Drugs August 31, 2015
Sampada Upadhye, PhD, indicates bioavailability enhancement with formulation and dose form flexibility can be achieved through the application of HME technology to produce stable drug formulations and increased development success rates.
DNA VACCINE TECHNOLOGY - A Vaccine Breakthrough That Could Change Lives & Enable Vaccine Development Programs August 31, 2015
William Hearl, PhD, asks what if there was the potential for a better and safer treatment for allergies, a less-toxic cancer therapy, or a breakthrough treatment to improve the health of a pet or valuable livestock? What if you could employ a new, patented technology that may make these treatments possible?
Enteris Biopharma's Formulation Technology Enables Oral Delivery of Cara Therapeutics' Peptide August 25, 2015
Enteris BioPharma, Inc. congratulates Cara Therapeutics on the dosing of the first patients in a Phase II trial of an...Catalent's Proprietary Softgel Technology Used to Provide Daily Dosing of Modified-Release Semi-Solid Formulation August 10, 2015
Catalent Pharma Solutions recently welcomed the announcement by OPKO Health that the US Food and Drug Administration has accepted for...Immune Pharmaceuticals Expands Immuno-Dermatology Development Portfolio June 12, 2015
Immune Pharmaceuticals Inc. recently announced it has entered into a binding Memorandum of Understanding with Yissum, the Technology Transfer Company...FORMULATION DEVELOPMENT - Overcoming Early Phase Development Challenges & Optimizing Formulations With a Minimal Amount of API June 2, 2015
ABSTRACT Softgel is a proven and effective delivery technology for poorly soluble drugs and can incorporate a wide range of...SPECIAL FEATURE - Outsourcing Formulation & Manufacturing Development: Using Data & Unique Approaches to Solve Solubility Issues, Target Profiles & Customize Products March 31, 2015
Contributor Cindy H. Dubin finds that CMOs are embracing development projects in an effort to establish longer-lasting partnerships with their pharma and biotech clients. These contract developers are deploying innovative techniques aimed at improving solubility and fast-tracking products to market.
Confluence Pharmaceuticals Signs Co-Development & Marketing Agreement March 27, 2015
Confluence Pharmaceuticals and AOP Orphan Pharmaceuticals AG recently announced they have signed a definitive agreement to co-develop and market Confluence’s lead...Immune Pharmaceuticals to Develop Novel Topical Nanoparticle Formulation March 24, 2015
Immune Pharmaceuticals Inc. recently announced it has entered into a binding memorandum of understanding with Yissum, the Technology Transfer Company...Combination Product Technology to Reach $31 Billion; Sector Attracting Massive Developmental Companies March 10, 2015
BCC Research reveals in its new report on drug-device combination products, developments in cell-based therapeutics, progenitor cell exploitation, growth factor...EXECUTIVE INTERVIEW - Ascendia Pharmaceuticals: Sophisticated Formulations for Poorly Soluble Drugs March 2, 2015
Jingjun (Jim) Huang, PhD, CEO, and Founder of Ascendia, discusses his company’s unique vision and strategy to provide pharmaceutical companies with a contract research partner that can provide technologies in order to efficiently determine which approach is most suitable for a given molecule.
Capsugel Acquires Ionic Liquids Technology January 12, 2015
Morristown, N.J., and Melbourne, Australia – Capsugel and Monash University recently announced that Capsugel has acquired the intellectual property pertaining...MRC Technology & Yabao Pharmaceuticals Announce Exclusive Partnership December 2, 2014
MRC Technology and Yabao Pharmaceutical Co, Inc. recently announced an exclusive license agreement to discover, develop, and commercialize innovative compounds...Company Profiles
Lyophilization Technology, Inc.
Lyophilization Technology, Inc. 30 Indian Drive Ivyland, PA 18974-1431 T: (215) 396-8373 F: (215) 396-8375 E: inquiry@lyo-t.com W: www.lyotechnology.com WHO...CycloLab Cyclodextrin Research & Development Ltd.
CycloLab Cyclodextrin Research & Development Ltd. E: commerce@cyclolab.hu W: cyclolab.hu LinkedIn: https://www.linkedin.com/company/10040240 For more than 30 years, Cyclolab Ltd. has been involved in...
